<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26562" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Intraductal Papillary Mucinous Neoplasm of the Pancreas</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Puckett</surname>
            <given-names>Yana</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharma</surname>
            <given-names>Bashar</given-names>
          </name>
          <aff>SUNY Upstate University Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kasi</surname>
            <given-names>Anup</given-names>
          </name>
          <aff>University of Kansas</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Yana Puckett declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bashar Sharma declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Anup Kasi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>14</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26562.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Intraductal papillary mucinous neoplasms (IPMNs) are cystic neoplasms of the pancreas that grow within the pancreatic ducts and produce mucin. They have the potential to become malignant, so it is important to diagnose and manage them early and appropriately. This activity reviews the evaluation and management of intraductal papillary mucinous neoplasms and highlights the role of the interprofessional team in the care of affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the epidemiology of intraductal papillary mucinous neoplasms.</p></list-item><list-item><p>Identify the types of intraductal papillary mucinous neoplasms.</p></list-item><list-item><p>Summarize the diagnosis and management of intraductal papillary mucinous neoplasms.</p></list-item><list-item><p>Explain the importance of collaboration and coordination among the interprofessional team to optimize outcomes for patients with intraductal papillary mucinous neoplasms.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26562&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26562">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26562.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Intraductal papillary mucinous neoplasms&#x000a0;(IPMN) are&#x000a0;cystic neoplasms&#x000a0;of the pancreas that grow&#x000a0;within the pancreatic ducts and produce&#x000a0;mucin. They have the potential to become malignant, for that reason; diagnostic criteria have been published to identify which&#x000a0;patients will require&#x000a0;surgical resection. The criteria usually involve anatomic identification based on imaging&#x000a0;including the size of the cyst, the presence of a nodule, architectural changes, obstruction of the main duct, and presence of symptoms.<xref ref-type="bibr" rid="article-26562.r1">[1]</xref><xref ref-type="bibr" rid="article-26562.r2">[2]</xref></p>
      </sec>
      <sec id="article-26562.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The risk factors of IPMNs are not clear. A few&#x000a0;conditions have been identified as possible risk factors for the development of IPMNs and&#x000a0;include diabetes (especially patients on insulin), chronic pancreatitis, and a family history of pancreatic ductal adenocarcinoma.<xref ref-type="bibr" rid="article-26562.r3">[3]</xref>&#x000a0;Smoking is an identified risk factor for pancreatic cancer <xref ref-type="bibr" rid="article-26562.r1">[1]</xref>&#x000a0;and has been associated with IPMNs as well.<xref ref-type="bibr" rid="article-26562.r4">[4]</xref></p>
      </sec>
      <sec id="article-26562.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The true incidence of IPMNs&#x000a0;is unknown as most of them&#x000a0;are small and asymptomatic. Studies that evaluated cross-sectional images of patients without a history of pancreatic lesions&#x000a0;have shown that approximately 2.6 - 13.5% of adults have pancreatic cysts and the incidence&#x000a0;correlated with increasing age.<xref ref-type="bibr" rid="article-26562.r5">[5]</xref><xref ref-type="bibr" rid="article-26562.r6">[6]</xref>&#x000a0;The age of presentation is typically between the 5th and 7th decades.<xref ref-type="bibr" rid="article-26562.r7">[7]</xref></p>
      </sec>
      <sec id="article-26562.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>IPMNs are thought to progress from benign neoplasms to invasive cancers through DNA damage/mutation. The damaged DNA loses protective factors and undergoes malignant degeneration leading to uncontrolled growth and convalescence.&#x000a0;KRAS and/or&#x000a0;GNAS mutations have been identified in IPMNs.<xref ref-type="bibr" rid="article-26562.r8">[8]</xref>&#x000a0;IPMNs can involve the&#x000a0;main pancreatic duct, a&#x000a0;branch duct or sometimes it can involve both and is considered a mixed duct&#x000a0;type. In all cases of main branch duct type involvement, surgical resection is recommended. Branch duct-type cases may be observed. Branch duct type IPMNs are generally believed to carry less risk of malignancy compared to main duct IPMNs&#x000a0;<xref ref-type="bibr" rid="article-26562.r9">[9]</xref>.</p>
      </sec>
      <sec id="article-26562.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>IPMNs originate from stem cells of the epithelium of the pancreatic ducts which can differentiate into different phenotypes. They can have different subtypes based on their differentiation including&#x000a0;intestinal, pancreaticobiliary, oncocytic, and gastric types.<xref ref-type="bibr" rid="article-26562.r10">[10]</xref>&#x000a0;IPMNs usually progress from benign neoplasms to invasive cancers. This progression is graded based on the degree of dysplasia as&#x000a0;low-grade dysplasia (adenoma), moderate dysplasia (borderline), high-grade dysplasia (carcinoma in situ), and finally invasive carcinoma.&#x000a0;The progression from adenoma to carcinoma has been estimated to take 5-6 years to happen and it depends on the subtype of the IPMN.<xref ref-type="bibr" rid="article-26562.r10">[10]</xref></p>
        <p>When IPMNs become invasive, two different subtypes of carcinoma have been identified;&#x000a0;tubular type, which usually arises from the&#x000a0;pancreatobiliary IPMN and is morphologically similar to&#x000a0;pancreatic ductal adenocarcinoma and colloid (mucinous) type, which usually arises from intestinal IPMNs&#x000a0;and is&#x000a0;morphologically characterized by extensive pools of mucin similar to cancers of other exocrine glands.<xref ref-type="bibr" rid="article-26562.r10">[10]</xref>&#x000a0;Colloid carcinomas have a better prognosis than tubular carcinomas <xref ref-type="bibr" rid="article-26562.r11">[11]</xref>.</p>
      </sec>
      <sec id="article-26562.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>IPMNs&#x000a0;can come to clinical attention in a variety of different ways. They&#x000a0;can be asymptomatic and detected incidentally on imaging. However; when symptoms are present, they are usually nonspecific including&#x000a0;abdominal pain, back pain, nausea, vomiting, anorexia, and weight loss. They can also present with jaundice caused by obstruction of the bile ducts due to external compression or invasion&#x000a0;or&#x000a0;pancreatitis-like symptoms due to obstruction of the main pancreatic duct by mucin.<xref ref-type="bibr" rid="article-26562.r12">[12]</xref></p>
      </sec>
      <sec id="article-26562.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The evaluation of IPMNs usually starts with imaging to evaluate the characteristics of the cyst, involvement of adjacent structures, and evidence of distant metastasis. Magnetic resonance imaging (MRI) with magnetic resonance cholangiopancreatography (MRCP) is first line. Computed tomography (CT) with pancreatic protocol is an alternative in patients whom MRIs are contraindicated. Endoscopic ultrasound (EUS) with fine-needle aspiration (FNA) should be used to assess cysts with malignant features, including large size, dilation of the main pancreatic duct, and/or presence of a solid component. Cystic fluid cytology can be assessed to look for atypical or malignant cells. Fluid markers, especially carcinoembryonic antigen (CEA), can help with the diagnosis as well. Cysts with a solid component and a dilated pancreatic duct or have malignant features on EUS and FNA should undergo surgical resection. Cysts with no concerning features should be monitored with MRIs.<xref ref-type="bibr" rid="article-26562.r13">[13]</xref><xref ref-type="bibr" rid="article-26562.r14">[14]</xref></p>
      </sec>
      <sec id="article-26562.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Surgery is indicated in&#x000a0;patients with IPMNs and high-grade dysplasia or IPMNs that have progressed to invasive carcinoma. Surgery is recommended for all mucinous neoplasms and main duct neoplasms. In cases of branch duct cysts, observation may be elected. For patients with invasive ductal adenocarcinoma of the pancreas, postresection adjuvant therapy improves survival, even in patients with positive margins or involved lymph nodes. There is controversy as to the best adjuvant strategy.&#x000a0;Due to the significant morbidity and mortality associated with pancreaticoduodenectomy or distal pancreatectomy, the patient's and surgeon's decision to perform surgery should include&#x000a0;factors such as the patient's age and general health, the malignant risk of the lesion, and the suspicion for malignancy. Cysts not meeting the criteria for resection are typically followed with surveillance imaging <xref ref-type="bibr" rid="article-26562.r15">[15]</xref>.</p>
        <p>If the main duct is greater than or equal to 1.5 cm, suitable patients should undergo surgical resection. If the whole duct is affected, then total pancreatectomy is the treatment of choice. If the head of the pancreas is affected, then Whipple's procedure (pancreaticoduodenectomy) is the operation of choice. If the tail of the pancreas is affected, then distal pancreatectomy plus or minus splenectomy may be warranted.</p>
      </sec>
      <sec id="article-26562.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differentials include pancreatic pseudocysts, serous cyst tumors, mucinous cyst neoplasms, and solid pseudopapillary neoplasms. Imaging including MRI,&#x000a0;MRCP, and&#x000a0;EUS with&#x000a0;FNA helps in differentiating IPMNs from other types of cysts.</p>
      </sec>
      <sec id="article-26562.s11" sec-type="Surgical Oncology">
        <title>Surgical Oncology</title>
        <p>For operative technique, an upper midline incision is made, once, inside the abdomen, entrance to lesser sac is created with harmonic scalpel. Kocherization of the duodenum is performed. Once the pancreas is identified,&#x000a0;the tissue&#x000a0;is dissected&#x000a0;where the IPMN is involved.&#x000a0;As much as possible, the pancreatic parenchyma should be preserved to ameliorate the side effects of diabetes mellitus and exocrine insufficiency secondary to missing pancreatic&#x000a0;tissue. One trick for intraoperative surgery is to palpate the duct of the pancreas. If it feels dilated, then it has to be resected as it needs to be assumed that it is dilated due to increased mucin production (abnormal). Confirm negative margins with a frozen section&#x000a0;by sending to pathology.</p>
      </sec>
      <sec id="article-26562.s12" sec-type="Radiation Oncology">
        <title>Radiation Oncology</title>
        <p>There is no role for radiation in the management of&#x000a0;IPMNs.</p>
      </sec>
      <sec id="article-26562.s13" sec-type="Medical Oncology">
        <title>Medical Oncology</title>
        <p>There is no indication for chemotherapy for IPMN as it is considered a premalignant condition. Currently, surgery is the mainstay of&#x000a0;therapy. If an invasive cancer component is identified after surgery then the patient needs adjuvant chemotherapy. The chemotherapy would be gemcitabine, or gemcitabine plus capecitabine or modified FOLFIRINOX for 6 months</p>
      </sec>
      <sec id="article-26562.s14" sec-type="Staging">
        <title>Staging</title>
        <p>Staging needs to be completed with CT of the chest, abdomen, and pelvis with intravenous contrast.</p>
      </sec>
      <sec id="article-26562.s15" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The 5-year survival for IPMNs&#x000a0;is about 45 to 50%&#x000a0;in comparison to pancreatic adenocarcinoma's 5-year survival of 8% <xref ref-type="bibr" rid="article-26562.r1">[1]</xref>.</p>
      </sec>
      <sec id="article-26562.s16" sec-type="Complications">
        <title>Complications</title>
        <p>After surgery, complications such as bleeding, anastomotic leak, abscess, or death can occur. Pancreatic enterocutaneous fistulas are a dreaded complication of pancreatic surgery for which to be aware. Typically, these are treated with total parenteral nutrition (TPN), nothing by mouth, and drainage and possibly somatostatin analogs <xref ref-type="bibr" rid="article-26562.r16">[16]</xref>.</p>
      </sec>
      <sec id="article-26562.s17" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>Early ambulation is recommended postoperatively. Drain placed at surgery should be removed after the oral diet is advanced and the patient tolerates a regular diet without an increase of drain output. If there is suspicion&#x000a0;of a pancreatic fistula, the fluid should be tested for amylase and lipase&#x000a0;which are expected to be elevated.&#x000a0;</p>
      </sec>
      <sec id="article-26562.s18" sec-type="Consultations">
        <title>Consultations</title>
        <p>Physical therapy, occupational therapy, and nutritional consultations may be suggested.</p>
      </sec>
      <sec id="article-26562.s19" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients need diabetes education. The patient needs to closely follow up with his primary care provider for diabetes management and prevention. Patients who smoke need to be given resources to quit smoking.</p>
      </sec>
      <sec id="article-26562.s20" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Patients&#x000a0;should undergo follow-up surveillance every 6 months for a year after the surgery with CT scans of the abdomen. If by 1 year nothing is seen, then patients can follow up annually and have imaging with MRCP to reduce radiation exposure.</p>
      </sec>
      <sec id="article-26562.s21" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Management of IPMNs requires an interprofessional&#x000a0;team consisting of an oncology&#x000a0;nurse, oncologist, surgeon, and pharmacist specializing in oncologic medications. The patient will require regular follow-ups by the team for best results. [Level 5]</p>
      </sec>
      <sec id="article-26562.s22">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26562&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26562">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/intraductal-papillary-mucinous-neoplasm-of-the-pancreas/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=26562">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26562/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26562">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-26562.s23">
        <title>References</title>
        <ref id="article-26562.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rawla</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sunkara</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gaduputi</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors.</article-title>
            <source>World J Oncol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <page-range>10-27</page-range>
            <pub-id pub-id-type="pmid">30834048</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26562.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pandit</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yadav</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Lacoul</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Awale</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Invasive Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas Causing Duodenal Infiltration and Obstruction: a Case Report.</article-title>
            <source>J Gastrointest Cancer</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>51</volume>
            <issue>1</issue>
            <fpage>292</fpage>
            <page-range>292-295</page-range>
            <pub-id pub-id-type="pmid">30903578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26562.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Capurso</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Boccia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Salvia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Del Chiaro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Frulloni</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Arcidiacono</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Zerbi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Manta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fabbri</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ventrucci</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tarantino</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Piciucchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carnuccio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boggi</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Leoncini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Costamagna</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Delle Fave</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pezzilli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bassi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Larghi</surname>
                <given-names>A</given-names>
              </name>
              <collab>Italian Association for Study of Pancreas (AISP)</collab>
              <collab>Intraductal Papillary Mucinous Neoplasm (IPMN) Study Group</collab>
            </person-group>
            <article-title>Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>108</volume>
            <issue>6</issue>
            <fpage>1003</fpage>
            <page-range>1003-9</page-range>
            <pub-id pub-id-type="pmid">23458848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26562.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fukushima</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mukai</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Pancreatic neoplasms with abundant mucus production: emphasis on intraductal papillary-mucinous tumors and mucinous cystic tumors.</article-title>
            <source>Adv Anat Pathol</source>
            <year>1999</year>
            <month>Mar</month>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>65</fpage>
            <page-range>65-77</page-range>
            <pub-id pub-id-type="pmid">10331069</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26562.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laffan</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Horton</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Berlanstein</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Siegelman</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Kawamoto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Fishman</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Hruban</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of unsuspected pancreatic cysts on MDCT.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>191</volume>
            <issue>3</issue>
            <fpage>802</fpage>
            <page-range>802-7</page-range>
            <pub-id pub-id-type="pmid">18716113</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26562.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Sekhar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rofsky</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Pedrosa</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of incidental pancreatic cysts in the adult population on MR imaging.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>105</volume>
            <issue>9</issue>
            <fpage>2079</fpage>
            <page-range>2079-84</page-range>
            <pub-id pub-id-type="pmid">20354507</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26562.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khalid</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brugge</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2007</year>
            <month>Oct</month>
            <volume>102</volume>
            <issue>10</issue>
            <fpage>2339</fpage>
            <page-range>2339-49</page-range>
            <pub-id pub-id-type="pmid">17764489</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26562.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Matthaei</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Maitra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dal Molin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Eshleman</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Goggins</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Canto</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Schulick</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Edil</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Wolfgang</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Diaz</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Kinzler</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Papadopoulos</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hruban</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Vogelstein</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.</article-title>
            <source>Sci Transl Med</source>
            <year>2011</year>
            <month>Jul</month>
            <day>20</day>
            <volume>3</volume>
            <issue>92</issue>
            <fpage>92ra66</fpage>
            <pub-id pub-id-type="pmid">21775669</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26562.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khader</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thyagarajan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sahu</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Exploring Signaling Pathways and Pancreatic Cancer Treatment Approaches Using Genetic Models.</article-title>
            <source>Mini Rev Med Chem</source>
            <year>2019</year>
            <volume>19</volume>
            <issue>14</issue>
            <fpage>1112</fpage>
            <page-range>1112-1125</page-range>
            <pub-id pub-id-type="pmid">30924420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26562.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gr&#x000fc;tzmann</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Niedergethmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pilarsky</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kl&#x000f6;ppel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Saeger</surname>
                <given-names>HD</given-names>
              </name>
            </person-group>
            <article-title>Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment.</article-title>
            <source>Oncologist</source>
            <year>2010</year>
            <volume>15</volume>
            <issue>12</issue>
            <fpage>1294</fpage>
            <page-range>1294-309</page-range>
            <pub-id pub-id-type="pmid">21147870</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26562.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Annese</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tamma</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ruggieri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ribatti</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Angiogenesis in Pancreatic Cancer: Pre-Clinical and Clinical Studies.</article-title>
            <source>Cancers (Basel)</source>
            <year>2019</year>
            <month>Mar</month>
            <day>18</day>
            <volume>11</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">30889903</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26562.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rivera</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-del Castillo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pins</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Compton</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Lewandrowski</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Rattner</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Warshaw</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Pancreatic mucinous ductal ectasia and intraductal papillary neoplasms. A single malignant clinicopathologic entity.</article-title>
            <source>Ann Surg</source>
            <year>1997</year>
            <month>Jun</month>
            <volume>225</volume>
            <issue>6</issue>
            <fpage>637</fpage>
            <page-range>637-44; discussion 644-6</page-range>
            <pub-id pub-id-type="pmid">9230804</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26562.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vege</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Ziring</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Moayyedi</surname>
                <given-names>P</given-names>
              </name>
              <collab>Clinical Guidelines Committee</collab>
              <collab>American Gastroenterology Association</collab>
            </person-group>
            <article-title>American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts.</article-title>
            <source>Gastroenterology</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>148</volume>
            <issue>4</issue>
            <fpage>819</fpage>
            <page-range>819-22; quize12-3</page-range>
            <pub-id pub-id-type="pmid">25805375</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26562.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elta</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Enestvedt</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Sauer</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Lennon</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>113</volume>
            <issue>4</issue>
            <fpage>464</fpage>
            <page-range>464-479</page-range>
            <pub-id pub-id-type="pmid">29485131</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26562.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klaiber</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Schnaidt</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Hinz</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Gaida</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Heger</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Hank</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Strobel</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Neoptolemos</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Mihaljevic</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>B&#x000fc;chler</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Hackert</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.</article-title>
            <source>Ann Surg</source>
            <year>2021</year>
            <month>Jan</month>
            <day>01</day>
            <volume>273</volume>
            <issue>1</issue>
            <fpage>154</fpage>
            <page-range>154-162</page-range>
            <pub-id pub-id-type="pmid">30921051</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26562.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Long</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ni</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Surgical Resection for Metastatic Tumors in the Pancreas: A Single-Center Experience and Systematic Review.</article-title>
            <source>Ann Surg Oncol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>26</volume>
            <issue>6</issue>
            <fpage>1649</fpage>
            <page-range>1649-1656</page-range>
            <pub-id pub-id-type="pmid">30924017</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
